Cargando…
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
Conventional anti-cancer therapies based on chemo- and/or radiotherapy represent highly effective means to kill cancer cells but lack tumor specificity and, therefore, result in a wide range of iatrogenic effects. A promising approach to overcome this obstacle is spliceosome-mediated RNA trans-splic...
Autores principales: | Woess, Katharina, Sun, Yuchen, Morio, Hanae, Stierschneider, Anna, Kaufmann, Anna, Hainzl, Stefan, Trattner, Lisa, Kocher, Thomas, Tockner, Birgit, Leb-Reichl, Victoria, Steiner, Markus, Brachtl, Gabriele, South, Andrew P., Bauer, Johann W., Reichelt, Julia, Furihata, Tomomi, Wally, Verena, Koller, Ulrich, Piñón Hofbauer, Josefina, Guttmann-Gruber, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745581/ https://www.ncbi.nlm.nih.gov/pubmed/35008999 http://dx.doi.org/10.3390/ijms23010575 |
Ejemplares similares
-
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
por: Bischof, Johannes, et al.
Publicado: (2022) -
A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa
por: Zwicklhuber, Janine, et al.
Publicado: (2023) -
COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa
por: Petković, Igor, et al.
Publicado: (2022) -
5′RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa
por: Mayr, Elisabeth, et al.
Publicado: (2022) -
An RNA-targeted therapy for dystrophic epidermolysis bullosa
por: Peking, Patricia, et al.
Publicado: (2017)